Winston & Strawn Prevails, Securing Nonbinary Runner’s Therapeutic Use Exemption From USADA

Nov 17, 2023

Winston & Strawn LLP has prevailed on behalf of nonbinary runner Cal Calamia in securing United States Anti-Doping Agency (USADA) approval of a Therapeutic Use Exemption (TUE) for Calamia’s use of testosterone in male, nonbinary, and open running categories. The USADA issued the approval on October 5, 2023. Calamia, who uses both “he” and “they” pronouns, has been taking testosterone as part of his gender transition after having been assigned female at birth. Winston has been re
This content is for subscribers only. Please subscribe or log in to read the rest of this article.

Articles in Current Issue